Welcome to our dedicated page for Health Advance I news (Ticker: HADV), a resource for investors and traders seeking the latest updates and insights on Health Advance I stock.
Health Advance Inc (OTC: HADV) generates news across several intersecting themes: health and wellness products, CBD and hemp-derived adult beverages, and social equity-focused cannabis ventures. Company releases highlight how Health Advance uses joint ventures and alliances to advance its charter mission in the health and wellness oriented marketplace.
Readers following HADV news can see updates on its Courtship Wines division and the 66° Beverage Company brand, which are associated with CBD infused de‑alcoholized wine beverages and, more recently, hemp derived THC beverage concepts. News items describe licensing milestones under New York State’s Cannabinoid Hemp Program, production starts, distribution from Western New York facilities, and evolving launch strategies based on test marketing and retailer interest.
Another key news theme is Health Advance’s alliance with SoEquity Corporation in a social equity cannabis accelerator model. Releases discuss how the Health Advance / SoEquity partnership mentors and finances social equity cannabis license owners in capped markets, enters into joint ventures such as with InLabs2 LLC, and aims to channel these opportunities to public shareholders.
Health Advance news also covers its nutraceutical and personal health initiatives, including immune-boosting supplement ranges and proprietary supplement kits for people experiencing lingering effects after COVID and similar infections, developed under the guidance of Dr. Alvin Pettle. For investors, analysts, and observers, the HADV news feed provides ongoing insight into how these beverage, nutraceutical, and cannabis-related projects progress through licensing, production, joint venture formation, and market testing.
Bookmark this page to review Health Advance Inc press releases and media updates as the company reports on its joint venture activities, product launches, and accelerator developments over time.
Health Advance Inc (OTC PINK:HADV) announced a joint venture named Health Advance CV to provide treatment options for individuals suffering from lingering effects post-COVID. The venture will offer curated nutraceutical pouches utilizing proprietary infusion techniques for improved efficacy. Led by Dr. Alvin Pettle, the initiative aims to simplify supplement combinations for better compliance. Health Advance CV will collaborate with leading contract manufacturers to produce quality health products, targeting the growing global demand. More updates will follow as the venture progresses.
Health Advance, Inc. (OTC PINK:HADV) has been awarded shared distributorship of the Rapid Response™ COVID-19 Antigen Rapid Test Device by BTNX, Inc. This development enables Health Advance to start sales of the approved COVID-19 testing device, which is critical for addressing the persistent effects of 'Long COVID.' The company, which has a solid track record in sales and training, is set to operate its distribution through a joint venture that will be detailed later. Moreover, the company plans to launch CBD infused beverages through a new subsidiary by Q4 2021.
Health Advance Inc (OTC PINK:HADV) has filed Annual Disclosure Reports for fiscal years ending March 31, 2020, and March 31, 2021, marking a return to accountability for shareholders after a reporting hiatus. The company is launching new CBD-infused wine products and has implemented plans for future business operations. Notably, these initiatives are being financed without convertible promissory debt, and management aims for profitable operations. Health Advance is targeting the Pink Current Information tier on OTC Markets and is committed to maintaining transparency with shareholders.
Health Advance, Inc. (OTC PINK:HADV) is launching a joint venture, Courtship Wines, to offer new CBD-infused wines globally. The initial products include 'Fit For A King', a Cabernet Sauvignon, and 'Fit For A Queen', a Pinot Grigio, each containing 40 mg of CBD per 750 ml. The brand uses proprietary infusion techniques for superior quality. Updates on production and operations will be provided in June, along with a new management discussion to enhance shareholder communication.
Health Advance, Inc (OTC PINK:HADV) has received approval for its application to the OTC Markets OTCIQ News and Information Service, which allows for Current Information filings under the Alternative Reporting Guidelines. The company will also apply to cease being an SEC reporting issuer. A significant reduction in outstanding shares from 320,947,500 to 160,947,500 has been made, attributed to share issuance cancellation. New president Larry McLachlin aims to enhance shareholder value through straightforward business operations focused on sales and cash flow.